The next forum for unraveling FDA off-label marketing rules: State and federal legislatures
Events
Loading … Spinner

Mendeley | Further Information

{"title"=>"The next forum for unraveling FDA off-label marketing rules: State and federal legislatures", "type"=>"journal", "authors"=>[{"first_name"=>"Michael S.", "last_name"=>"Sinha"}, {"first_name"=>"Aaron S.", "last_name"=>"Kesselheim"}], "year"=>2018, "source"=>"PLOS Medicine", "identifiers"=>{"doi"=>"10.1371/journal.pmed.1002564", "issn"=>"1549-1676"}, "id"=>"9d4e86fa-7253-345e-97ed-1ac52fd8e2e0", "abstract"=>"In a Guest Editorial, Aaron S. Kesselheim and Michael S. Sinha show how federal and state legislation to allow promotion of drugs for non-approved uses threatens to undermine the FDA's public health mission.", "link"=>"http://www.mendeley.com/research/next-forum-unraveling-fda-offlabel-marketing-rules-state-federal-legislatures", "reader_count"=>1, "reader_count_by_academic_status"=>{"Researcher"=>1}, "reader_count_by_user_role"=>{"Researcher"=>1}, "reader_count_by_subject_area"=>{"Medicine and Dentistry"=>1}, "reader_count_by_subdiscipline"=>{"Medicine and Dentistry"=>{"Medicine and Dentistry"=>1}}, "group_count"=>0}

Scopus

{"@_fa"=>"true", "error"=>"Result set was empty"}

Twitter

Counter

  • {"month"=>"5", "year"=>"2018", "pdf_views"=>"114", "xml_views"=>"880", "html_views"=>"549"}
Loading … Spinner
There are currently no alerts